Cargando…
Structure of the second phosphoubiquitin–binding site in parkin
Parkin and PINK1 regulate a mitochondrial quality control system that is mutated in some early onset forms of Parkinson’s disease. Parkin is an E3 ubiquitin ligase and regulated by the mitochondrial kinase PINK1 via a two-step cascade. PINK1 first phosphorylates ubiquitin, which binds a recruitment...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284454/ https://www.ncbi.nlm.nih.gov/pubmed/35690145 http://dx.doi.org/10.1016/j.jbc.2022.102114 |
_version_ | 1784747563528749056 |
---|---|
author | Fakih, Rayan Sauvé, Véronique Gehring, Kalle |
author_facet | Fakih, Rayan Sauvé, Véronique Gehring, Kalle |
author_sort | Fakih, Rayan |
collection | PubMed |
description | Parkin and PINK1 regulate a mitochondrial quality control system that is mutated in some early onset forms of Parkinson’s disease. Parkin is an E3 ubiquitin ligase and regulated by the mitochondrial kinase PINK1 via a two-step cascade. PINK1 first phosphorylates ubiquitin, which binds a recruitment site on parkin to localize parkin to damaged mitochondria. In the second step, PINK1 phosphorylates parkin on its ubiquitin-like domain (Ubl), which binds a regulatory site to release ubiquitin ligase activity. Recently, an alternative feed-forward mechanism was identified that bypasses the need for parkin phosphorylation through the binding of a second phosphoubiquitin (pUb) molecule. Here, we report the structure of parkin activated through this feed-forward mechanism. The crystal structure of parkin with pUb bound to both the recruitment and regulatory sites reveals the molecular basis for differences in specificity and affinity of the two sites. We use isothermal titration calorimetry measurements to reveal cooperativity between the two binding sites and the role of linker residues for pUbl binding to the regulatory site. The observation of flexibility in the process of parkin activation offers hope for the future design of small molecules for the treatment of Parkinson's disease. |
format | Online Article Text |
id | pubmed-9284454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Biochemistry and Molecular Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92844542022-07-19 Structure of the second phosphoubiquitin–binding site in parkin Fakih, Rayan Sauvé, Véronique Gehring, Kalle J Biol Chem Accelerated Communication Parkin and PINK1 regulate a mitochondrial quality control system that is mutated in some early onset forms of Parkinson’s disease. Parkin is an E3 ubiquitin ligase and regulated by the mitochondrial kinase PINK1 via a two-step cascade. PINK1 first phosphorylates ubiquitin, which binds a recruitment site on parkin to localize parkin to damaged mitochondria. In the second step, PINK1 phosphorylates parkin on its ubiquitin-like domain (Ubl), which binds a regulatory site to release ubiquitin ligase activity. Recently, an alternative feed-forward mechanism was identified that bypasses the need for parkin phosphorylation through the binding of a second phosphoubiquitin (pUb) molecule. Here, we report the structure of parkin activated through this feed-forward mechanism. The crystal structure of parkin with pUb bound to both the recruitment and regulatory sites reveals the molecular basis for differences in specificity and affinity of the two sites. We use isothermal titration calorimetry measurements to reveal cooperativity between the two binding sites and the role of linker residues for pUbl binding to the regulatory site. The observation of flexibility in the process of parkin activation offers hope for the future design of small molecules for the treatment of Parkinson's disease. American Society for Biochemistry and Molecular Biology 2022-06-08 /pmc/articles/PMC9284454/ /pubmed/35690145 http://dx.doi.org/10.1016/j.jbc.2022.102114 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Accelerated Communication Fakih, Rayan Sauvé, Véronique Gehring, Kalle Structure of the second phosphoubiquitin–binding site in parkin |
title | Structure of the second phosphoubiquitin–binding site in parkin |
title_full | Structure of the second phosphoubiquitin–binding site in parkin |
title_fullStr | Structure of the second phosphoubiquitin–binding site in parkin |
title_full_unstemmed | Structure of the second phosphoubiquitin–binding site in parkin |
title_short | Structure of the second phosphoubiquitin–binding site in parkin |
title_sort | structure of the second phosphoubiquitin–binding site in parkin |
topic | Accelerated Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284454/ https://www.ncbi.nlm.nih.gov/pubmed/35690145 http://dx.doi.org/10.1016/j.jbc.2022.102114 |
work_keys_str_mv | AT fakihrayan structureofthesecondphosphoubiquitinbindingsiteinparkin AT sauveveronique structureofthesecondphosphoubiquitinbindingsiteinparkin AT gehringkalle structureofthesecondphosphoubiquitinbindingsiteinparkin |